The abstract is read at the publisher; the summary is JClub's.
Consensus guidance for treatment response assessment in endemic mycoses was developed, covering clinical, mycologic, and radiologic criteria to standardize trial endpoints across diverse pathogens.
- Why it matters: Existing response guidance from 2008 was mainly designed for invasive yeast and mold infections and is inadequate for endemic mycoses with complex, heterogeneous presentations in immunocompetent and immunocompromised hosts.
- What they did: An international expert panel used a structured literature review, expert deliberation, regulatory consultation, patient input, and public comment to produce consensus-based response criteria for endemic mycoses.
- The result: The criteria are intended to improve accuracy and standardize treatment response evaluation, enabling comparison and pooling of results across clinical trials for these endemic fungal infections.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.